Biochemical and connective tissue changes in cyclophosphamide-induced lung fibrosis in rats

Biochemical Pharmacology

Volumn 56, Issue 7, 1998, Pages 895-904

  Venkatesan, Narayanan ^a   Punithavathi, Durairaj ^b   Chandrakasan, Gowri ^a  

^a CENTRAL LEATHER RESEARCH INSTITUTE   (India)

^b UNIVERSITY OF MADRAS   (India)

Author keywords

Collagen; Collagenase; Cyclophosphamide; Histamine; Lung fibrosis; Serotonin

Indexed keywords

COLLAGEN; COLLAGENASE; CYCLOPHOSPHAMIDE; DIPEPTIDYL CARBOXYPEPTIDASE; DNA; ELASTIN; FUCOSE; GLYCOPROTEIN; GLYCOSAMINOGLYCAN; HEXOSAMINE; HISTAMINE; HYDROXYPROLINE; SEROTONIN; SIALIC ACID; URONIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COLLAGEN SYNTHESIS; CONNECTIVE TISSUE; CONTROLLED STUDY; DNA SYNTHESIS; HYPERPLASIA; INFLAMMATION; LUNG FIBROSIS; MALE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RAT;

ANIMALS; BODY WEIGHT; BRONCHOALVEOLAR LAVAGE FLUID; COLLAGEN; CONNECTIVE TISSUE; CYCLOPHOSPHAMIDE; DNA; ENZYME ACTIVATION; EXTRACELLULAR MATRIX; GLYCOSAMINOGLYCANS; GLYCOSIDE HYDROLASES; HYDROXYPROLINE; INJECTIONS, INTRAPERITONEAL; LUNG; MALE; ORGAN SIZE; PEPTIDE HYDROLASES; PEPTIDYL-DIPEPTIDASE A; PEROXIDASE; PULMONARY FIBROSIS; RATS; RATS, WISTAR;

EID: 0032190039     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(98)00221-4     Document Type: Article

References (63)

1. Gould V.E., Miller J. Sclerosing alveolitis induced by cyclophosphamide. Am J Pathol. 81:1975;513-530.
2. Morse C.C., Sigler C., Lock S., Hakkinen P.J., Haschek W.M., Witschi H.P. Pulmonary toxicity of cyclophosphamide A 1-year study . Exp Mol Pathol. 42:1985;251-260.
3. Malik S.W., Myers J.L., DeRemee R.A., Specks U. Lung toxicity associated with cyclophosphamide use. Two distinct patterns. Am J Respir Crit Care Med. 154:1996;1851-1856.
4. Cooper J.A.D. Jr, White D.A., Matthay R.A. Drug induced pulmonary disease. Am Rev Respir Dis. 133:1986;321-340.
5. Kanekal S., Fraiser L., Kehrer J.P. Pharmacokinetics, metabolic activation and lung toxicity of cyclophosphamide in C57/B16 and ICR mice. Toxicol Appl Pharmacol. 114:1992;1-8.
6. Kehrer J.P., Margolin S.B. Pirfenidone diminishes cyclophosphamide-induced lung fibrosis in mice. Toxicol Lett. 90:1997;125-132.
7. Kumar R.K., Truscott J.Y., Rhodes G.C., Lykke J.W.A. Type 2 pneumocyte responses to cyclophosphamide-induced pulmonary injury Functional and morphological correlation . Br J Exp Pathol. 69:1988;69-80.
8. Crouch E. Pathophysiology of pulmonary fibrosis. Am J Physiol. 259:1990;L159-L184.
9. Venkatesan N., Chandrakasan G. Cyclophosphamide induced early biochemical changes in lung lavage fluid and alterations in lavage cell function. Lung. 172:1994;147-158.
10. Witschi H.P., Saheb W. Stimulation of DNA synthesis in mouse lung following intraperitoneal injection of butylated hydroxytoluene. Proc Soc Exp Biol Med. 147:1974;690-693.
11. Ramos C., Montano M., Gonzalez G., Vadillo F., Selman M. Collagen metabolism in experimental lung silicosis. A trimodal behaviour of collagenolysis. Lung. 166:1988;347-353.
12. 14C in collagen and noncollagenous proteins. Anal Biochem. 57:1974;1-7.
13. Mahin D.T., Lofberg R.T. A simplified method of sample preparation for determination of tritium, carbon-14 or sulfur-35 in blood or tissue by liquid scintillation counting. Anal Biochem. 16:1966;500-509.
14. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin phenol reagent. J Biol Chem. 193:1951;265-275.
15. Burton K. A study of the mechanisms and condition of the diphenylamine reaction for the colorimetric estimation of deoxyribonucleic acid. Biochem J. 62:1956;315-323.
16. Cushman D.W., Cheung H.S. Spectrophotometric assay and properties of the angiotensin converting enzyme of rabbit lung. Biochem Pharmacol. 20:1971;1637-1647.
17. Shore P.A. Fluorimetric assay of histamine. Methods Enzymol. 27B:1971;842-845.
18. Hanbrich D.R., Denzer J.S. Simultaneous extraction and fluorimetric measurement of brain serotonin, catecholamines, 5-hydroxyindoleacetic acid and homovanillic acid. Anal Biochem. 55:1973;306-312.
19. Bradley P.P., Priebat D.A., Christensen R.D., Rothstein G. Measurement of cutaneous inflammation Estimation of neutrophil content with an enzyme marker . J Invest Dermatol. 78:1982;206-209.
20. Christner P., Fein A., Goldberg S., Lippmann M., Abrams W., Weinbaum G. Collagenase in the lower respiratory tract of patients with adult respiratory distress syndrome. Am Rev Respir Dis. 131:1985;690-695.
21. Woessner J.F. Jr. Total, latent and active collagenase during the course of post-partum involution of the rat uterus. Effect of oestradiol. Biochem J. 180:1979;95-102.
22. Anderson A.J. Effect of lysosomal collagenolytic enzymes, anti-inflammatory drugs and other substances on some properties of insoluble collagen. Biochem J. 113:1969;457-463.
23. Kawai Y., Anno K. Mucopolysaccharide-degrading enzymes from the liver of the squid Ommastrephees sloani pacificus. Biochim Biophys Acta. 242:1971;428-436.
24. Moore J.C., Morris J.W. A simple automated colorimetric method for determination of N-acetyl-β-D-glucosaminidase. Ann Clin Biochem. 19:1982;157-159.
25. Woessner J.F. Jr. The determination of hydroxyproline in tissue and protein samples containing small proportions of this imino acid. Arch Biochem Biophys. 93:1961;440-447.
26. Neuman R.E., Logan M.A. Determination of collagen and elastin in tissues. J Biol Chem. 186:1950;549-556.
27. Bitter T., Muir H.M. A modified uronic acid carbazole reaction. Anal Biochem. 4:1962;330-334.
28. Boas N.F. Method for the determination of hexosamines in tissues. J Biol Chem. 204:1953;553-563.
29. Dische Z., Shettles L.B. A specific color reaction of methylpentoses and a spectrophotometric micromethod for their determination. J. Biol Chem. 175:1948;595-603.
30. Warren L. The thiobarbituric acid assay of sialic acids. J Biol Chem. 234:1959;1971-1975.
31. Dubois M., Gilles K.A., Hamilton J.K., Rebers P.A., Smith F. Colorimetric method for determination of sugars and related substances. Anal Chem. 28:1956;350-356.
32. Bains G.S., Dhake G.S. Late effects of cyclophosphamide treatment of neonatal mice. Indian J Exp Biol. 30:1992;205-210.
33. Hollinger M.A., Giri S.N., Patwell S., Zuckerman J.E., Gorin A., Parsons G. Effect of acute lung injury on angiotensin converting enzyme in serum, lung lavage and effusate. Am Rev Respir Dis. 121:1980;373-376.
34. Hollinger M.A., Patwell S., Zuckerman J.E., Gorin A.B., Parsons G., Giri S.N. Effect of paraquat on serum angiotensin converting enzyme. Am Rev Respir Dis. 121:1980;795-798.
35. Hakkinen P.J., Whiteley J.W., Witschi H.P. Hyperoxia, but not thoracic X-irradiation, potentiates bleomycin and cyclophosphamide-induced lung damage. Am Rev Respir Dis. 126:1982;281-285.
36. Smith R.D., Kehrer J.P. Cooxidation of cyclophosphamide as an alternative pathway for its bioactivation and lung toxicity. Cancer Res. 51:1991;542-548.
37. Witschi H., Godfrey G., Frome E., Lindenschmidt R.C. Pulmonary toxicity of cytostatic drugs Cell kinetics . Fundam Appl Toxicol. 8:1987;253-262.
38. Crapo J.D., Barry B.E., Gehr P., Bachofen M., Weibel E.R. Cell number and cell characteristics of the normal human lung. Am Rev Respir Dis. 126:1982;332-337.
39. Haschek W.M., Klein-Szanto A.J.P., Last J.A., Reiser K.M., Witschi H. Long-term morphologic and biochemical features of experimentally induced lung fibrosis in the mouse. Lab Invest. 46:1982;438-449.
40. Adamson I.Y.R., Bowden D.H. Role of polymorphonuclear leukocytes in silica-induced pulmonary fibrosis. Am J Pathol. 117:1984;37-43.
41. Hunninghake G.W., Gadek J.E., Kawanami O., Ferrans V.J., Crystal R.G. Inflammatory and immune processes in the human lung in health and disease Evaluation by bronchoalveolar lavage . Am J Pathol. 97:1979;149-206.
42. Weiland J.E., Davis W.B., Holter J.F., Mohammed J.R., Dorinsky P.M., Gadek J.E. Lung neutrophils in the adult respiratory distress syndrome. Clinical and pathophysiologic significance. Am Rev Respir Dis. 133:1986;218-225.
43. Gadek J.E., Fells G.A., Zimmerman R.L., Crystal R.G. Role of connective tissue proteases in the pathogenesis of chronic inflammatory lung disease. Environ Health Perspect. 55:1984;297-306.
44. Janoff A., White R., Carp H., Harvel S., Dearing R., Lee D. Lung injury induced by leukocytic proteases. Am J Pathol. 97:1979;111-135.
45. Riley D.J., Kerr J.S. Oxidant injury of the extracellular matrix Potential role in the pathogenesis of pulmonary emphysema . Lung. 163:1985;1-13.
46. Schraufstatter I.U., Browne K., Harris A., Hyslop P.A., Jackson J.H., Quehenberger O., Cochrane C.G. Mechanism of hypochlorite injury of target cells. J Clin Invest. 85:1990;554-562.
47. Gadek J.E., Kelman J.A., Fells G., Weinberger S.E., Horwitz A.L., Reynolds H.Y., Fulmer J.D., Crystal R.G. Collagenase in the lower respiratory tract of patients with idiopathic pulmonary fibrosis. N Engl J Med. 301:1979;737-742.
48. Riley D.J., Kramer M.J., Kerr J.S., Chae C.U., Yu S.Y., Berg R.A. Damage and repair of lung connective tissue in rats exposed to toxic levels of oxygen. Am Rev Respir Dis. 135:1987;441-447.
49. Stevens L.R., Austen K.F. Recent advances in the cellular and molecular biology of mast cells. Immunol Today. 10:1989;386-391.
50. Aldenborg F., Nilsson K., Jarlshammar B., Bjermer L., Enerback L. Mast cells and biogenic amines in radiation-induced pulmonary fibrosis. Am J Respir Cell Mol Biol. 8:1993;112-117.
51. Kawanami O., Ferrans V.J., Fulmer J.D., Crystal R.G. Ultrastructure of pulmonary mast cells in patients with fibrotic lung disorders. Lab Invest. 40:1979;717-734.
52. Hawkins R.A., Claman H.N., Clark R.A.F., Steigerwald J.C. Increased dermal mast cell populations in progressive systemic sclerosis A link in chronic fibrosis . Ann Intern Med. 102:1985;182-186.
53. Keith I., Day R., Lemaire S., Lemaire I. Asbestos-induced fibrosis in rats Increase in lung mast cells and autocoid contents . Exp Lung Res. 13:1987;311-327.
54. Religa Z., Maslinski C.Z. Histamine metabolism in experimental silicosis. II. In vivo experiments in guinea pigs. Life Sci. 10:1971;257-271.
55. Tomioka M., Goto T., Lee D.G., Bienenstock J., Befus D. Isolation and characterization of lung mast cells from rats with bleomycin-induced pulmonary fibrosis. Immunology. 66:1989;439-444.
56. O'Connor C.M., O'Brien A., Sweeney E.C., Fitzgerald M.X. Progress of bleomycin-induced lung fibrosis in rabbits. Br J Exp Pathol. 67:1986;461-467.
57. Hampson E.C.G.M., Pond S.M. Ultrastructure of canine lung during the proliferative phase of paraquat toxicity. Br J Exp Pathol. 69:1988;57-68.
58. Durham S.K., Gijbels M.J.J. Long-term morphologic and biochemical changes induced by O,O,S-trimethyl phosphorothioate in the rat lung. Toxicol Appl Pharmacol. 98:1989;465-474.
59. Heppleston A.G. Minerals, fibrosis and the lung. Environ Health Perspect. 94:1991;149-168.
60. Venkatesan N, Punithavathi D and Chandrakasan G, Glycoprotein composition in cyclophosphamide-induced fibrosis. Biochim Biophys Acta, in press.
61. Chandrasekaran L., Seethalakshmi S., Chandrakasan G., Dhar S.C. Alterations in lung and skin compositions of rat in bleomycin-induced fibrosis. Biochem Med Metab Biol. 38:1987;205-212.
62. Ross R. The fibroblast and wound repair. Biol Rev. 43:1968;51-96.
63. Dvorak H.F. Tumors Wounds that do not heal. Similarities between tumor stroma generation and wound healing . N Engl J Med. 315:1986;1650-1659.